Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cequa in Sjogren's Syndrome-associated dry eye
NCT04835623Phase 4Completed
- Sponsor
- Center for Ophthalmic and Vision Research
- Start
- Jun 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine ophthalmic solution in dry eye disease (DED), sponsored by Center for Ophthalmic and Vision Research. Started Jun 2021; status: completed.
02
Drugs
cyclosporine ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04835623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04835623.